TMCI earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Hold, P/E -4.09. Updated 2026-07-23.
Treace Medical Concepts (TMCI) Research Hub
Treace Medical Concepts (TMCI) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 4.51 USD (-0.44%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.09, market cap 0.26B. This hub links to the full technical, earnings and options research available for TMCI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.51 USD (-0.44%) |
| 52-week range | 3.8 USD – 5.2 USD |
| Trend regime | Range |
| 14-day RSI | 43.3 (Bearish) |
| Trailing P/E | -4.09 |
| Market cap | 0.26B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for TMCI
Covered Call on TMCI: how it works, illustrative setup around the real 4.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TMCI: how it works, illustrative setup around the real 4.51 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TMCI: how it works, illustrative setup around the real 4.51 USD price, max profit/loss, breakeven and when to use it. Educational.
TMCI technical analysis: range, last 4.51 USD, RSI 43.3, 52w range 3.8 USD–5.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TMCI in?
Treace Medical Concepts (TMCI) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is TMCI in an uptrend or downtrend?
As of 2026-09-11, TMCI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TMCI's trailing P/E ratio?
TMCI's trailing P/E is -4.09, with a market cap of 0.26B. See the earnings research page for full valuation detail.
When does TMCI next report earnings?
TMCI is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -0.3 USD.